Royalty Pharma Ownership | Who Owns Royalty Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

Royalty Pharma Ownership Summary

Royalty Pharma is owned by 68.21% institutional investors, 13.78% insiders, and 18.02% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.84% of RPRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.77% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Royalty Pharma	68.21%	13.78%	18.02%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	44.13M	9.84%	$1.16B
Vanguard group	37.35M	8.34%	$952.90M
Fmr	26.38M	5.89%	$672.94M
Blackrock funding, inc. /de	25.45M	5.68%	$649.14M
Blackrock	23.02M	5.13%	$606.97M
Adage capital partners gp	16.97M	3.79%	$432.86M
Baillie gifford	14.13M	3.16%	$360.57M
Viking global investors lp	12.21M	2.73%	$311.42M
Swedbank ab	12.16M	2.72%	$310.31M
State street	9.49M	2.11%	$250.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Siguler guff advisers	2.37M	30.11%	$60.44M
Cutter capital management, lp	764.86K	8.00%	$19.51M
Gmt capital	3.27M	4.06%	$83.36M
Regal partners	1.44M	3.71%	$36.63M
Cm management	160.00K	3.65%	$4.08M
Patient capital management	2.88M	3.38%	$73.34M
New south capital management	2.96M	3.18%	$75.44M
Torray investment partners	684.01K	2.50%	$17.45M
Menlo advisors	133.24K	1.73%	$3.40M
Cannon global investment management	30.50K	1.69%	$778.05K

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	16.97M	0.76%	5.07M
Norges bank	4.88M	0.02%	4.88M
Blackrock funding, inc. /de	25.45M	0.01%	3.15M
Blackrock	23.02M	0.01%	1.81M
Bnp paribas arbitrage, snc	1.64M	0.02%	1.64M

Top Sellers

Holder	Shares	% Assets	Change
Unisphere establishment	-	-	-5.00M
Baillie gifford	14.13M	0.28%	-1.99M
Millennium management	2.42M	0.03%	-1.93M
Suvretta capital management	-	-	-1.87M
Janus henderson group	34.24K	0.00%	-1.73M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	4.88M	0.02%	4.88M	$124.50M
Bnp paribas arbitrage, snc	1.64M	0.02%	1.64M	$41.96M
Raymond james financial	783.63K	0.01%	783.63K	$19.99M
Samlyn capital	726.02K	0.28%	726.02K	$18.52M
Caisse de depot et placement du quebec	712.78K	0.04%	712.78K	$18.18M

Sold Out

Holder	Change
Tfc financial management	-1.00
Financial gravity asset management	-2.00
Central trust	-3.00
Harbor investment advisory	-4.00
Advisornet financial	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	382	-3.78%	305,326,416	-0.72%	68	1.45%	210	-2.78%	129	6.61%
Sep 30, 2024	394	3.14%	307,455,539	-2.73%	68	1.40%	214	6.47%	120	-4.76%
Jun 30, 2024	377	-1.57%	316,067,573	2.80%	70	1.49%	201	-8.22%	123	6.03%
Mar 31, 2024	383	4.36%	307,459,490	0.67%	68	1.48%	219	-2.67%	116	7.41%
Dec 31, 2023	367	14.69%	305,416,427	4.62%	68	1.62%	225	32.35%	108	-6.90%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	12.01M	2.77%	-167.60K
Vanguard Total Stock Mkt Idx Inv	11.89M	2.74%	6.44K
Vanguard Mid Cap Index Institutional	8.16M	1.88%	38.04K
Vanguard Institutional Extnd Mkt Idx Tr	5.81M	1.34%	24.30K
MS INVF US Advantage I	5.59M	1.29%	-344.30K
Morgan Stanley Growth SMA	5.35M	1.20%	-350.63K
Morgan Stanley Growth	5.35M	1.20%	-350.63K
Morgan Stanley Inst Growth I	5.05M	1.16%	-655.52K
MS INVF US Growth I	4.48M	1.03%	-
Swedbank Robur Aktiefond Pension	4.09M	0.94%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 02, 2024	RIGGS RORY B	-	Sell	$6.71M
Jan 04, 2024	RIGGS RORY B	-	Sell	$983.50K
Jan 03, 2024	RIGGS RORY B	-	Sell	$5.53M
Dec 29, 2023	Avara Management Ltd	-	Sell	$1.85M
Dec 27, 2023	Avara Management Ltd	-	Sell	$1.17M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	3

RPRX Ownership FAQ

Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 68.21%, followed by 13.78% insiders and 18.01% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 68.48%, which Royalty Pharma falls below.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (44.13M shares, 9.84%), Vanguard group (37.35M shares, 8.34%), and Fmr (26.38M shares, 5.89%). Together, they hold 24.08% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Siguler guff advisers is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 30.11% of its assets in 2.37M Royalty Pharma shares, valued at 60.44M$.

Who is the top mutual fund holder of Royalty Pharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Royalty Pharma shares, with 2.77% of its total shares outstanding invested in 12.01M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools